People · Operator

F. David Rollo

Named in public records as an officer, director or promoter · active 2008–2008 · Biotechnology

1
Companies
2
Filings
$57.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Cell Point, LLCBiotechnologySeries B$57.5M$99.9M2008
Operator network

F. David Rollo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Jerry Bryant · 4 companies · 1 sharedJerry BryantF. David A. Rollo · 1 companies · 1 sharedF. David A. RolloFrank David Rollo · 1 companies · 1 sharedFrank David RolloGreg Colip · 1 companies · 1 sharedGreg ColipGreg R. Colip · 1 companies · 1 sharedGreg R. ColipGreg Russel Colip · 1 companies · 1 sharedGreg Russel ColipGreg Russell Colip · 1 companies · 1 sharedGreg Russell ColipJerry A. Bryant, Jr. · 1 companies · 1 sharedJerry A. Bryant, …Jerry Bryant, Jr. · 1 companies · 1 sharedJerry Bryant, Jr.Jerry Russel Bryant · 1 companies · 1 sharedJerry Russel Brya…Jerry Russell Bryant · 1 companies · 1 sharedJerry Russell Bry…Terry A. Colip · 1 companies · 1 sharedTerry A. ColipTerry Allen Colip · 1 companies · 1 sharedTerry Allen ColipTerry Colip · 1 companies · 1 sharedTerry ColipCell Point, LLC · $57.5M raisedCell Point, LLCF. David RolloFR
F. David Rollo Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside F. David Rollo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jerry Bryant14
Terry Allen Colip11
Jerry Russell Bryant11
Greg Russell Colip11
Greg Russel Colip11
Jerry Russel Bryant11
Jerry Bryant, Jr.11
Greg R. Colip11
Terry A. Colip11
Jerry A. Bryant, Jr.11
F. David A. Rollo11
Greg Colip11
Frank David Rollo11
Terry Colip11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.